Brett Belongia
Corporate Officer/Principal bij ONCORUS, INC.
Profiel
Brett Belongia is currently working as Vice President-CMC Operations at Oncorus, Inc. He previously worked as Director-Technical Operations at Momenta Pharmaceuticals, Inc. Dr. Belongia completed his undergraduate degree from the University of Wisconsin and his doctorate degree from the University of Arizona.
Actieve functies van Brett Belongia
| Bedrijven | Functie | Begin |
|---|---|---|
| ONCORUS, INC. | Corporate Officer/Principal | - |
Eerdere bekende functies van Brett Belongia
| Bedrijven | Functie | Einde |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van Brett Belongia
| University of Arizona | Doctorate Degree |
| University of Wisconsin | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ONCORUS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
